Safety of Outpatient CAR T-Cell Therapy May Be Improved With Integrated Management Process
The utilization of remote patient monitoring within the first 30 days of outpatient CAR T-cell therapy can promote patient safety, reduce costs, and decrease hospitalization rates by allowing patients with hematologic malignancies to connect with a virtual care platform.
Source: onclive.com